The UMT detected malaria in 419 (25%) of participants, while BinaxNOW tests that detect the HRP-2 antigen of Plasmodium falciparum (BinaxNOW Pf) and aldolase, a pan-malaria antigen found in all Plasmodium species (BinaxNOW Pan), detected malaria in 676 (40%) and 368 (22%) of participants, respectively. This evidence concerns the gene HDGFL2 and malaria.